Antihistamines are effective for treatment of seasonal nasal allergy. Recently, prophylactic treatment with antihistamines in patients with pollinosis was reported to be more effective when started before the pollen season. The administration with antihistamines from 2 to 6 weeks before onset of the pollen season is recommended for management of allergic rhinitis in Japan. To determine the reason for the effectiveness of prophylactic treatment with antihistamines, the effects of repeated pre-treatment with antihistamines before provocation with toluene 2,4-diisocyanate (TDI) on their nasal allergy-like behavior and up-regulations of histamine H(1) receptors (H1R) and interleukin (IL)-4 mRNAs in their nasal mucosa were examined. Provocation with TDI induced sneezing and up-regulations of H1R and IL-4 mRNAs in the nasal mucosa of TDI-sensitized rats. Repeated pre-treatments with antihistamines including epinastine, olopatadine, or d-chlorpheniramine for 1 to 5 weeks before provocation with TDI suppressed TDI-induced sneezing and the up-regulations of H1R and IL-4 mRNAs in the nasal mucosa more than their administrations once or for 3 days before TDI provocation. Our data indicate that repeated pre-treatment with antihistamines before provocation with TDI is more effective than their single treatment in reducing nasal allergy-like behavior by causing additional suppression of up-regulations of H1R and IL-4 mRNAs in the nasal mucosa.

Download full-text PDF

Source
http://dx.doi.org/10.1254/jphs.08222fpDOI Listing

Publication Analysis

Top Keywords

il-4 mrnas
16
mrnas nasal
16
nasal mucosa
16
repeated pre-treatment
12
pre-treatment antihistamines
12
provocation tdi
12
up-regulations h1r
12
h1r il-4
12
antihistamines
8
up-regulations histamine
8

Similar Publications

Lipid nanoparticles encapsulating both adjuvant and antigen mRNA improve influenza immune cross-protection in mice.

Biomaterials

December 2024

Center for Inflammation, Immunity & Infection, Institute for Biomedical Science, Georgia State University, Atlanta, GA, USA. Electronic address:

Article Synopsis
  • The study highlights the success of mRNA lipid nanoparticle (LNP) vaccines in quickly addressing urgent vaccine needs, but notes their limitations in generating mucosal responses and broad protection against variants.
  • Researchers engineered an advanced mRNA LNP vaccine that includes a novel cytokine adjuvant and influenza A antigen, resulting in strong antibody and T cell responses in mice.
  • Two different adjuvants, GIFT4 and CCL27, were shown to effectively enhance both humoral and cellular immune responses, indicating the potential of cytokine mRNA as a versatile component in mRNA vaccine formulations for improved immunity against viruses.
View Article and Find Full Text PDF
Article Synopsis
  • Long noncoding RNAs (lncRNAs) have been linked to various immune diseases, but their role in allergic rhinitis (AR) due to house dust mites is not fully understood.
  • The study aimed to analyze the expression patterns and functions of lncRNAs in the blood of AR patients, using sequencing and bioinformatics to identify differences between these patients and healthy controls.
  • Results indicated that four specific lncRNAs were significantly upregulated in AR patients, showing correlations with allergy symptoms and inflammatory cytokines, suggesting potential diagnostic and therapeutic roles for these lncRNAs in AR management.
View Article and Find Full Text PDF

The role of PAR2 in regulating MIF release in house dust mite-induced atopic dermatitis.

Front Immunol

October 2024

Department of Dermatology, Peking University First Hospital, Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, National Clinical Research Center for Skin and Immune Disease, National Medical Products Administration (NMPA) Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing, China.

Atopic dermatitis (AD) is a chronic disease characterized by relapsed eczema and intractable itch, and is often triggered by house dust mites (HDM). PAR2 is a G-protein coupled receptor on keratinocytes and may be activated by HDM to affect AD processes. We first established a HDM-derived AD mouse model in wild-type (WT) and mice.

View Article and Find Full Text PDF

Probiotic Bacillus subtilis QST713 improved growth performance and enhanced the intestinal health of yellow-feather broilers challenged with coccidia and Clostridium perfringens.

Poult Sci

December 2024

Key Laboratory of Animal Disease-resistant Nutrition, Ministry of Education, Institute of Animal Nutrition, Sichuan Agricultural University, Sichuan Province, Chengdu 611130, China. Electronic address:

Article Synopsis
  • A study looked at how adding a special bacteria called Bacillus subtilis (BS) to chicken feed helps yellow feather broilers stay healthy when they are sick with germs like Coccidia and Clostridium perfringens (CP).
  • The researchers divided 600 young roosters into different groups and measured things like how much they grew, how well they ate, and the health of their intestines over 80 days.
  • Results showed that when the chickens got sick, they gained less weight and had more intestinal problems, but adding BS helped improve their growth and health compared to the sick chickens without the bacteria.
View Article and Find Full Text PDF

Background: We aim to investigate the effect of YiQi GuBen formula (YQGB) on airway inflammation and airway remodeling in the ovalbumin (OVA)-induced asthma model to further explore the potential mechanisms of YQGB in treating allergic asthma.

Methods: Mice were divided into five groups randomly (n = 10): the control group, OVA group, OVA + Dex (0.1 mg/kg) group, OVA + low-dose (1.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!